An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images.
aortitis
convolutional neural network
machine learning
positron emission tomography/computed tomography
radiomics
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
09 02 2023
09 02 2023
Historique:
received:
23
11
2022
revised:
30
01
2023
accepted:
01
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
The aim of this study was to develop and validate an automated pipeline that could assist the diagnosis of active aortitis using radiomic imaging biomarkers derived from [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) images. The aorta was automatically segmented by convolutional neural network (CNN) on FDG PET-CT of aortitis and control patients. The FDG PET-CT dataset was split into training (43 aortitis:21 control), test (12 aortitis:5 control) and validation (24 aortitis:14 control) cohorts. Radiomic features (RF), including SUV metrics, were extracted from the segmented data and harmonized. Three radiomic fingerprints were constructed: A-RFs with high diagnostic utility removing highly correlated RFs; B used principal component analysis (PCA); C-Random Forest intrinsic feature selection. The diagnostic utility was evaluated with accuracy and area under the receiver operating characteristic curve (AUC). Several RFs and Fingerprints had high AUC values (AUC > 0.8), confirmed by balanced accuracy, across training, test and external validation datasets. Good diagnostic performance achieved across several multi-centre datasets suggests that a radiomic pipeline can be generalizable. These findings could be used to build an automated clinical decision tool to facilitate objective and standardized assessment regardless of observer experience.
Identifiants
pubmed: 36830712
pii: biom13020343
doi: 10.3390/biom13020343
pmc: PMC9953018
pii:
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Radiopharmaceuticals
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MR/N011775/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211100/Z/18/Z
Pays : United Kingdom
Références
Circulation. 2008 Jun 10;117(23):3039-51
pubmed: 18541754
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Br J Surg. 2015 Feb;102(3):148-58
pubmed: 25627261
J Nucl Med. 2019 Sep;60(Suppl 2):38S-44S
pubmed: 31481588
J Nucl Cardiol. 2019 Feb;26(1):59-67
pubmed: 30120746
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2790-2799
pubmed: 31482428
J Nucl Cardiol. 2022 Aug;29(4):2001-2010
pubmed: 33982202
Eur J Radiol. 2010 Mar;73(3):504-9
pubmed: 20172676
Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):344-53
pubmed: 22072285
J Nucl Cardiol. 2019 Oct;26(5):1755-1758
pubmed: 29679221
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1250-1269
pubmed: 29637252
Arthritis Rheumatol. 2018 Mar;70(3):439-449
pubmed: 29145713
Insights Imaging. 2020 Aug 12;11(1):91
pubmed: 32785796
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1016-1039
pubmed: 33106926
Sci Rep. 2021 Aug 30;11(1):17389
pubmed: 34462502
Cardiovasc Pathol. 2015 Sep-Oct;24(5):267-78
pubmed: 26051917
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Neuroimage. 2018 Feb 15;167:104-120
pubmed: 29155184
Diagnostics (Basel). 2021 Oct 26;11(11):
pubmed: 34829332
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1119-1128
pubmed: 29671039
Ophthalmology. 2006 Oct;113(10):1842-5
pubmed: 16884778
Semin Nucl Med. 2021 Mar;51(2):126-133
pubmed: 33509369
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
J Nucl Cardiol. 2022 Dec;29(6):3315-3331
pubmed: 35322380
J Nucl Cardiol. 2021 Oct;28(5):1872-1874
pubmed: 31832886
Br J Radiol. 2017 Feb;90(1070):20160665
pubmed: 27936886
Cancers (Basel). 2021 Jun 18;13(12):
pubmed: 34207102
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2656-2672
pubmed: 31214791
J Nucl Cardiol. 2016 Jun;23(3):590-5
pubmed: 26187420
J Nucl Med. 2022 Feb;63(2):280-286
pubmed: 34088771
Cancers (Basel). 2021 Apr 13;13(8):
pubmed: 33924382
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2630-2637
pubmed: 31280350
Q J Nucl Med Mol Imaging. 2018 Mar;62(1):34-39
pubmed: 29166756
J Nucl Cardiol. 2020 Feb;27(1):156-158
pubmed: 29923100
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):340-348
pubmed: 26250689
Medicine (Baltimore). 2015 Sep;94(37):e1542
pubmed: 26376404
Rheumatology (Oxford). 2020 Mar 1;59(3):e1-e23
pubmed: 31970405
Phys Med. 2021 Mar;83:108-121
pubmed: 33765601
Radiology. 2022 Jun;303(3):533-541
pubmed: 35230182
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3886-3902
pubmed: 33942141
Heart. 2021 Oct;107(20):1620-1629
pubmed: 33593995
Radiology. 2003 Dec;229(3):831-7
pubmed: 14593193
Radiologe. 2018 Nov;58(Suppl 1):1-6
pubmed: 29922965
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
J Nucl Med. 2022 Feb;63(2):172-179
pubmed: 34531263
Curr Cardiol Rep. 2019 Mar 18;21(5):34
pubmed: 30887249
Ann Rheum Dis. 2018 May;77(5):636-643
pubmed: 29358285
Curr Opin Rheumatol. 2014 Jan;26(1):24-30
pubmed: 24257367
Medicine (Baltimore). 2015 Apr;94(14):e622
pubmed: 25860208
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
RMD Open. 2019 Sep 16;5(2):e001003
pubmed: 31673411
J Nucl Med. 2018 Aug;59(8):1321-1328
pubmed: 29301932
EJNMMI Res. 2021 Feb 25;11(1):19
pubmed: 33630176